Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-09-19
2000-08-01
Carlson, Karen Cochrane
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 530350, 530825, A01N 3718, C07K 14325
Patent
active
060967080
ABSTRACT:
Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used to transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
REFERENCES:
patent: 4448885 (1984-05-01), Schnepf et al.
patent: 4467036 (1984-08-01), Schnepf et al.
patent: 5273746 (1993-12-01), Payne et al.
patent: 5407825 (1995-04-01), Payne et al.
patent: 5460963 (1995-10-01), Botterman et al.
Schnepf, H. Ernest, and H.R. Whiteley (1951) "Cloning and Expression of the Bacillus thuringiensis Crystal Protein gene in Escherichia coli" Proc. Nat'l Acad. Sci. USA 75(5): 2893-2897.
Payne Jewel
Sick August J.
Bugaisky Gabriele E.
Carlson Karen Cochrane
Mycogen Corporation
LandOfFree
Bacillus thuringiensis isolate active against lepidopteran pests does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bacillus thuringiensis isolate active against lepidopteran pests, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bacillus thuringiensis isolate active against lepidopteran pests will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-663892